Laird Norton Wetherby Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
+2,530
| New | +$1.33M | 0.06% | 298 |
|
|
2024
Q4 | $1.66M | Sell |
2,326
-164
| -7% | -$117K | 0.08% | 233 |
|
|
2024
Q3 | $2.62M | Sell |
2,490
-31
| -1% | -$32.6K | 0.12% | 172 |
|
|
2024
Q2 | $2.65M | Sell |
2,521
-43
| -2% | -$45.2K | 0.12% | 161 |
|
|
2024
Q1 | $2.47M | Sell |
2,564
-34
| -1% | -$32.7K | 0.12% | 178 |
|
|
2023
Q4 | $2.28M | Sell |
2,598
-11
| -0.4% | -$9.66K | 0.12% | 171 |
|
|
2023
Q3 | $2.15M | Sell |
2,609
-35
| -1% | -$28.8K | 0.12% | 169 |
|
|
2023
Q2 | $1.9M | Sell |
2,644
-109
| -4% | -$78.3K | 0.1% | 198 |
|
|
2023
Q1 | $2.26M | Buy |
2,753
+126
| +5% | +$104K | 0.13% | 156 |
|
|
2022
Q4 | $1.9M | Buy |
2,627
+135
| +5% | +$97.4K | 0.12% | 185 |
|
|
2022
Q3 | $1.72M | Buy |
2,492
+240
| +11% | +$165K | 0.12% | 174 |
|
|
2022
Q2 | $1.33M | Sell |
2,252
-166
| -7% | -$98.1K | 0.09% | 232 |
|
|
2022
Q1 | $1.69M | Buy |
2,418
+108
| +5% | +$75.4K | 0.1% | 197 |
|
|
2021
Q4 | $1.46M | Buy |
2,310
+47
| +2% | +$29.7K | 0.08% | 226 |
|
|
2021
Q3 | $1.37M | Buy |
2,263
+40
| +2% | +$24.2K | 0.08% | 221 |
|
|
2021
Q2 | $1.24M | Buy |
2,223
+254
| +13% | +$142K | 0.08% | 247 |
|
|
2021
Q1 | $931K | Sell |
1,969
-245
| -11% | -$116K | 0.07% | 274 |
|
|
2020
Q4 | $1.07M | Buy |
2,214
+123
| +6% | +$59.4K | 0.07% | 251 |
|
|
2020
Q3 | $1.17M | Buy |
2,091
+62
| +3% | +$34.7K | 0.1% | 191 |
|
|
2020
Q2 | $1.27M | Buy |
2,029
+197
| +11% | +$123K | 0.12% | 167 |
|
|
2020
Q1 | $895K | Buy |
1,832
+318
| +21% | +$155K | 0.1% | 208 |
|
|
2019
Q4 | $569K | Buy |
1,514
+541
| +56% | +$203K | 0.06% | 371 |
|
|
2019
Q3 | $270K | Sell |
973
-109
| -10% | -$30.2K | 0.03% | 577 |
|
|
2019
Q2 | $338K | Sell |
1,082
-481
| -31% | -$150K | 0.04% | 497 |
|
|
2019
Q1 | $642K | Sell |
1,563
-15
| -1% | -$6.16K | 0.08% | 293 |
|
|
2018
Q4 | $589K | Buy |
1,578
+235
| +17% | +$87.7K | 0.08% | 280 |
|
|
2018
Q3 | $543K | Buy |
1,343
+444
| +49% | +$180K | 0.07% | 336 |
|
|
2018
Q2 | $310K | Sell |
899
-114
| -11% | -$39.3K | 0.04% | 467 |
|
|
2018
Q1 | $349K | Sell |
1,013
-676
| -40% | -$233K | 0.05% | 441 |
|
|
2017
Q4 | $635K | Buy |
1,689
+99
| +6% | +$37.2K | 0.09% | 277 |
|
|
2017
Q3 | $711K | Buy |
1,590
+10
| +0.6% | +$4.47K | 0.11% | 235 |
|
|
2017
Q2 | $776K | Buy |
1,580
+320
| +25% | +$157K | 0.13% | 195 |
|
|
2017
Q1 | $488K | Buy |
1,260
+133
| +12% | +$51.5K | 0.09% | 293 |
|
|
2016
Q4 | $414K | Sell |
1,127
-71
| -6% | -$26.1K | 0.08% | 313 |
|
|
2016
Q3 | $482K | Buy |
1,198
+402
| +51% | +$162K | 0.1% | 266 |
|
|
2016
Q2 | $278K | Buy |
796
+18
| +2% | +$6.29K | 0.06% | 374 |
|
|
2016
Q1 | $280K | Sell |
778
-112
| -13% | -$40.3K | 0.07% | 346 |
|
|
2015
Q4 | $483K | Buy |
890
+68
| +8% | +$36.9K | 0.12% | 208 |
|
|
2015
Q3 | $383K | Buy |
822
+179
| +28% | +$83.4K | 0.1% | 254 |
|
|
2015
Q2 | $328K | Buy |
643
+106
| +20% | +$54.1K | 0.08% | 297 |
|
|
2015
Q1 | $242K | Buy |
537
+43
| +9% | +$19.4K | 0.06% | 377 |
|
|
2014
Q4 | $203K | Buy |
+494
| New | +$203K | 0.05% | 424 |
|